RedHill Biopharma (RDHL) Debt Ratio (2020 - 2022)
RedHill Biopharma (RDHL) posted quarterly Debt Ratio of 1.45 for Q4 2022, up 214.28% year-over-year from 0.46 in Q4 2021, and up 100.25% quarter-over-quarter from 0.72 in Q3 2022.
RedHill Biopharma (RDHL) Debt Ratio (2020 - 2022) Analysis & Trends
RedHill Biopharma (RDHL) has reported Debt Ratio for 3 consecutive years, with 1.45 the latest figure, recorded in Q4 2022.
- In Q4 2022, Debt Ratio rose 214.28% year-over-year to 1.45; the TTM figure through Dec 2022 stood at 1.45 (up 214.28% YoY), while the FY2022 annual figure was 1.45, up 214.28% from the prior year.
- Debt Ratio improved to 1.45 in Q4 2022 per RDHL's latest filing, from 0.72 in the prior quarter.
- Across five years, Debt Ratio topped out at 1.45 in Q4 2022 and bottomed at 0.37 in Q1 2021.
- Historically, Debt Ratio has averaged 0.61 across 3 years, with a median of 0.48 in 2020.
- Annual changes were most pronounced in 2021 — Debt Ratio tumbled 31.18% — and 2022, when it jumped 214.28%.
- RedHill Biopharma's Debt Ratio stood at 0.45 in 2020, then increased by 2.21% to 0.46 in 2021, then surged by 214.28% to 1.45 in 2022.
- Business Quant data shows RDHL's Debt Ratio at 1.45 in Q4 2022, 0.72 in Q3 2022, and 1.02 in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -0.13 |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 0.42 |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 0.60 |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 0.32 |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 0.38 |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 0.29 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 0.12 |
| 10 | RedHill Biopharma | 2.05 Bn | 2.05 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 1.45 |
| Sep 30, 2022 | 0.72 |
| Jun 30, 2022 | 1.02 |
| Mar 31, 2022 | 0.52 |
| Dec 31, 2021 | 0.46 |
| Sep 30, 2021 | 0.45 |
| Jun 30, 2021 | 0.41 |
| Mar 31, 2021 | 0.37 |
| Dec 31, 2020 | 0.45 |
| Sep 30, 2020 | 0.48 |
| Jun 30, 2020 | 0.48 |
| Mar 31, 2020 | 0.54 |